MXPA03000650A - Compuesto farmaceuticamente activo. - Google Patents
Compuesto farmaceuticamente activo.Info
- Publication number
- MXPA03000650A MXPA03000650A MXPA03000650A MXPA03000650A MXPA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A MX PA03000650 A MXPA03000650 A MX PA03000650A
- Authority
- MX
- Mexico
- Prior art keywords
- active compound
- pharmaceutically active
- pharmaceutically
- compound
- active
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0017822.8A GB0017822D0 (en) | 2000-07-21 | 2000-07-21 | Pharmaceutically active compound |
| PCT/GB2001/003232 WO2002007771A1 (en) | 2000-07-21 | 2001-07-19 | Pharmaceutically active compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03000650A true MXPA03000650A (es) | 2003-06-06 |
Family
ID=9896025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03000650A MXPA03000650A (es) | 2000-07-21 | 2001-07-19 | Compuesto farmaceuticamente activo. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20040053896A1 (es) |
| EP (1) | EP1301212A1 (es) |
| JP (1) | JP2004504359A (es) |
| KR (1) | KR20030024800A (es) |
| CN (1) | CN1452498A (es) |
| AU (1) | AU2001270865A1 (es) |
| CA (1) | CA2416608A1 (es) |
| GB (1) | GB0017822D0 (es) |
| MX (1) | MXPA03000650A (es) |
| WO (1) | WO2002007771A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050066459A1 (en) * | 2003-09-09 | 2005-03-31 | The Procter & Gamble Company | Electric toothbrushes and replaceable components |
| CN107686498B (zh) * | 2016-08-05 | 2020-11-27 | 首都医科大学 | 阿霉素-胆酸缀合物,其合成,活性和应用 |
| CN110804082B (zh) * | 2019-11-25 | 2020-11-17 | 中国医学科学院医药生物技术研究所 | 一种胆酸类衍生物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4220598A (en) * | 1977-11-14 | 1980-09-02 | Abbott Laboratories | Method and reagents for measuring the level of conjugated bile acids |
| JPS62175497A (ja) * | 1986-01-28 | 1987-08-01 | Wakunaga Pharmaceut Co Ltd | 胆汁酸誘導体およびその製造法 |
| IT1283182B1 (it) * | 1996-03-04 | 1998-04-16 | Prodotti Chimici Alimentari | Composti coniugati di acidi biliari con tio-taurina e suoi n-alchilderivati |
| GB9716962D0 (en) * | 1997-08-12 | 1997-10-15 | Univ Birmingham | Liver function test |
-
2000
- 2000-07-21 GB GBGB0017822.8A patent/GB0017822D0/en not_active Ceased
-
2001
- 2001-07-19 JP JP2002513504A patent/JP2004504359A/ja active Pending
- 2001-07-19 WO PCT/GB2001/003232 patent/WO2002007771A1/en not_active Application Discontinuation
- 2001-07-19 KR KR10-2003-7000911A patent/KR20030024800A/ko not_active Application Discontinuation
- 2001-07-19 MX MXPA03000650A patent/MXPA03000650A/es unknown
- 2001-07-19 AU AU2001270865A patent/AU2001270865A1/en not_active Abandoned
- 2001-07-19 US US10/333,525 patent/US20040053896A1/en not_active Abandoned
- 2001-07-19 CN CN01815228A patent/CN1452498A/zh active Pending
- 2001-07-19 EP EP01949749A patent/EP1301212A1/en not_active Withdrawn
- 2001-07-19 CA CA002416608A patent/CA2416608A1/en not_active Abandoned
-
2005
- 2005-03-16 US US11/082,164 patent/US20050239712A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040053896A1 (en) | 2004-03-18 |
| KR20030024800A (ko) | 2003-03-26 |
| AU2001270865A1 (en) | 2002-02-05 |
| CA2416608A1 (en) | 2002-01-31 |
| GB0017822D0 (en) | 2000-09-06 |
| EP1301212A1 (en) | 2003-04-16 |
| JP2004504359A (ja) | 2004-02-12 |
| WO2002007771A1 (en) | 2002-01-31 |
| US20050239712A1 (en) | 2005-10-27 |
| CN1452498A (zh) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1050367A1 (en) | Pharmaceutically active compounds. | |
| GB9924020D0 (en) | Pharmaceutically active compounds | |
| IL146117A0 (en) | New pharmaceutically active compounds | |
| GB9823101D0 (en) | Pharmaceutically active compounds | |
| HK1037453A1 (en) | Earphone. | |
| IL137346A0 (en) | Pharmaceutically active morpholinol | |
| HK1048306A1 (en) | Pharmaceutically active sulfonamide derivatives. | |
| ZA200006352B (en) | Compound napkin. | |
| IL140974A0 (en) | Active prompts | |
| ZA200200106B (en) | Orally active androgens. | |
| GB9823102D0 (en) | Pharmaceutically active compounds | |
| GB0105893D0 (en) | Pharmaceutically active compounds | |
| GB0107751D0 (en) | Pharmaceutically active compounds | |
| GB0106631D0 (en) | Pharmaceutically active compounds | |
| AU6036100A (en) | New pharmaceutically active compounds | |
| MXPA03000650A (es) | Compuesto farmaceuticamente activo. | |
| HK1055954A1 (en) | Crystalline therapeutic agent. | |
| GB0007345D0 (en) | Pharmaceutically active compounds | |
| GB0018656D0 (en) | Pharmaceutically active compounds | |
| GB0018660D0 (en) | Pharmaceutically active compounds | |
| GB9926630D0 (en) | Pharmacologically active compounds | |
| GB0219897D0 (en) | Pharmaceutically active compounds | |
| GB0106562D0 (en) | Pharmaceutically active compounds | |
| GB0106617D0 (en) | Pharmaceutically active compounds | |
| GB0106561D0 (en) | Pharmaceutically active compounds |